Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Implementation of Precision Medicine in High-risk Prostate Cancer
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Other: High-risk treatment SOCOther: Active monitoringProcedure: Radical prostatectomyDrug: Androgen deprivation therapyRadiation: Radiotherapy
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Andreas Josefsson
- Target Recruit Count
- 5500
- Registration Number
- NCT06687421
- Locations
- 🇸🇪
Urology, Umeå University Hospital, Region Västerbotten, Umeå, Sweden
Enzalutamide Treatment in COVID-19
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Andreas Josefsson
- Target Recruit Count
- 42
- Registration Number
- NCT04475601
- Locations
- 🇸🇪
Anders Bjartell, Malmö, Skåne, Sweden
🇸🇪Ryhovs Hospital, Jönköping, Småland, Sweden
🇸🇪Sahlgrenska University Hospital, Gothenburg, Sweden
News
No news found